On May 21, 2025, the Federal Trade Commission (FTC) issued its third round of warning letters – and its first under the Trump administration – against pharmaceutical manufacturers for allegedly improper listing of patents in...more
6/4/2025
/ Antitrust Provisions ,
Antitrust Violations ,
Enforcement Actions ,
FDA Approval ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Orange Book ,
Patent Litigation ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Trump Administration